NCT03591133View on ClinicalTrials.gov

Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 24, 2015

Primary Completion Date

April 14, 2016

Study Completion Date

April 14, 2016

Conditions
Healthy Participants
Interventions
DRUG

TS-143

DRUG

Placebo

Trial Locations (1)

Unknown

Taisho Pharmaceutical Co., Ltd selected site, Tokyo

All Listed Sponsors
lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT03591133 - Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration) | Biotech Hunter | Biotech Hunter